Hurdles of Accessing HIV Treatment Among Homeless People Who Use Nyaope in Mogale City, Gauteng Province: An Exploratory Qualitative Study
Betty Popi Ndlovu, Kebogile Elizabeth Mokwena, Mohora Feida Malebatja

TL;DR
This study explores why homeless people who use a drug called nyaope in South Africa struggle to access HIV treatment, highlighting social and personal barriers.
Contribution
The study identifies specific barriers to HIV treatment access among homeless individuals who use nyaope, offering insights for targeted interventions.
Findings
Social exclusion and lack of support systems hinder HIV treatment access for homeless drug users.
Nyaope dependency and withdrawal symptoms interfere with consistent HIV treatment adherence.
Misconceptions about drug-HIV treatment interactions and negative peer influence further complicate treatment access.
Abstract
Background/Objectives: The growing intersection between nyaope use and HIV infection constitutes a critical public health problem that undermines efforts to achieve universal access to HIV treatment in South Africa. Nyaope use is strongly associated with the increased risk of HIV of transmission. A significant amount of new HIV infections was linked to substance use through sharing of injectable needles. Despite significant progress made to increase public awareness and increase accessibility to HIV services, little is known about how addiction, stigma, and discrimination influence access to HIV treatment among homeless individuals who nyaope. This study explored the hurdles of accessing HIV treatment among people who use nyaope and are homeless in Mogale City, Gauteng Province. Methods: An exploratory descriptive qualitative research approach was employed among people who are homeless,…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
- —National Research Foundation
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHIV, Drug Use, Sexual Risk · HIV/AIDS oral health manifestations · HIV, TB, and STIs Epidemiology
1. Introduction
Nyaope is a South African illicitly manufactured substance that contains several drug components such as heroin, cocaine, antiretroviral drugs, and marijuana [1,2,3,4,5,6,7]. Many researchers agree that its main ingredients include antiretroviral therapy, poison for rats, cannabis, heroin, detergent, pool cleaner, and battery acid [8,9,10]. The exact composition of nyaope is not standardized as it often varies across geographic locations [8,9,10]. In South Africa, where the study was conducted nyaope is also called “whoonga” [11,12], nyaope is usually smoked as a cigarette or injected into the blood stream by many people residing in various townships in South Africa [11,12].
Approximately, 20% of nyaope users have reported to be HIV positive in South Africa across various population groups [10,13,14]. Nyaope is known for its significant risk of dependency syndrome [13,15,16]. Some of the risky behaviours associated with the use of nyaope among PHHIVN include sharing of injectable needles, multiple intimate relationships, poly substance use, criminal behaviours, transactional unprotected sex and poor adherence to ART [17,18,19]. Its extensive availability in numerous South African communities facilitates habitual use among susceptible populations [16,20]. The combination of affordability, intense effects, and social determinants further increases the likelihood of dependence among users [12,13,16]. Nyaope’s addictive nature of nyaope contributes to elevated relapse rates [16,21,22], which are often linked not only to chemical dependence but also to psychosocial factors such as withdrawal symptoms, poor mental health, lack of support, and adverse environments [14,16,23]. These persistent relapses highlight the need for targeted interventions [15,16,21].
Despite global progress in addressing the HIV/AIDS pandemic, low- and middle-income countries continue to face major obstacles [1,2]. A major barrier is unequal access to HIV testing and antiretroviral therapy (ART), which is often influenced by national wealth, health infrastructure, and overall political will [3,4,5]. Although awareness and healthcare access have improved, many individuals still struggle to access treatment [1]. In 2022, about 9.2 million people living with HIV remained untreated, while approximately 5.5 million were unaware of their HIV status due to limited HIV testing services [6].
PHHIVN encounter multiple social and structural hurdles that limit their ability to access and continue with HIV treatment [13,24,25]. Social challenges encompass persistent stigma and discrimination from families, healthcare providers, and the broader community, which lead to feelings of shame and isolation [26]. Lack of family support and limited understanding of ART adherence further reduce engagement to care [10,27]. Structurally, challenges such as lack of a permanent physical address, concerns about the storage and security of medication while residing on the streets, and limited time to attend clinic appointments pose additional barriers to treatment [15,28]. Research also underscores that negative experiences in healthcare settings, including prolonged waiting times and unfriendly or judgmental staff attitudes, deter many substance users and people living with HIV from seeking care [14,15,16]. Collectively, these intertwined social and structural factors create a complex environment of exclusion and disengagement from health services.
Situations such as living on the streets or homeless are more common among PHHIVN exposing them to poor access to basic services, mental health conditions, poor nutrition and poor hygiene [24,29]. A study reveals that there is a correlation between homelessness and HIV amongst people using drugs [24]. Furthermore, mental health conditions such as depression act as barriers to ART initiation and adherence amongst people who use drugs [30,31]. Research has shown that addressing co-occurring mental health disorders can improve ART uptake and adherence among people who use drugs [30,32].
Significant correlations exist between nyaope usage and HIV status [10,13]. A considerable quantity of individuals living with HIV have been reported to use nyaope [12,13,15]. Poverty, low education, and poor access to healthcare contribute to both substance use and HIV vulnerability, particularly among disadvantaged youth [8,9,33]. These socioeconomic conditions reinforce a cycle of dependence and risk of infection. Incarceration further compounds these barriers, as people who use nyaope are frequently arrested for possession or related survival crimes such as theft and burglary [8,13,14,33,34]. Such experiences disrupt continuity of HIV treatment and rehabilitation services.
South Africa has taken steps to curb HIV spread and increase HIV treatment accessibility in recent years [35,36,37,38]. Starting from the year 2004, the South African Department of Health implemented availability of antiretroviral therapy free of charge at primary health care facilities nationwide [35,36,37,38]. While national HIV strategies have improved life expectancy and reduced HIV related morbidity [13,39,40,41], few interventions are specifically tailored to the needs of substance using populations. Current evidence suggests that the health system remains ill-equipped to provide specialized, integrated services for homeless individuals who use nyaope [42,43]. This study therefore aimed to explore the hurdles of accessing HIV treatment among PHHIVN in Mogale City, Gauteng Province, to better understand the personal, social, and structural barriers affecting their treatment engagement.
2. Materials and Methods
2.1. Study Area
This study was conducted at Non-Profit Organization (NPO) in Mogale City, Gauteng Province. The NPO provides HIV testing services and distribution of harm reduction packs to people who inject drugs, including those who use nyaope. The organization serves more than 100 clients living with HIV who use nyaope from various locations across Mogale City.
2.2. Study Design, Population, and Recruitment
An exploratory descriptive qualitative design was followed to explore the hurdles of accessing HIV treatment among PHHIVN in Mogale City, Gauteng Province. This is a suitable research design, that gives provision to investigate and explore a phenomenon of interest in depth such as the hurdles of accessing HIV treatment among homeless individuals who use nyaope. The target population for this study was PHHIVN in Mogale City, Gauteng Province. PHHIVN, above 18 years, who were addicted to nyaope over the past 6 months, who were willing to participate and give consent to participate were included in this study as participants. PHHIVN, above 18 years, who were addicted to nyaope over the past 6 months, but not willing to participate and give informed consent were excluded in this study. A sample size of 25 was reached, determined by data saturation. Data saturation is a stage where participants are no longer providing new information. Emerging codes were monitored from the data itself while checking with field notes to confirm data saturation. After the third round of fieldwork, no new information emerged. The researcher and supervisors evaluated the data and reached a consensus that data saturation was reached.
Permission to conduct the study was obtained from the NPO management and Sefako Makgtho Health Sciences University Research Committee (SMUREC/H/484/2023:PG). The researcher recruited potential participants in collaboration with the NPO. The researcher engaged with each participant individually, providing a briefing on the study. The purpose of the study was explained to each potential participant and those who were willing to participate, they were requested to go to the data collection room. Informed consent, both verbal and written, was obtained from participants prior to their involvement in the study, adhering to institutional and national ethical guidelines. Participants were duly informed that their involvement in the study was entirely voluntary, and they retained the right to terminate their participation at any point without incurring any repercussions concerning their eligibility for services provided by the NPO. To enhance privacy measures, all interviews were conducted within a confidential setting, specifically in a private room at the NPO. During the data collection and transcription phases, no names or identifiable details were documented. Instead, codes replaced personal identifiers, and access to the encrypted data files was restricted exclusively to the research team.
2.3. Data Collection
Data collection commenced post receiving clearance approval from SMUREC. Participants who agreed to form part of the study verbally were also requested to sign informed consent forms and identify themselves before any participants.
Data was collected through face-to-face in-depth interviews between May and August 2024. The study was guided by the Comprehensive Theory of Substance Abuse Prevention [44]. This theory provides a thorough explanation of substance misuse behaviours and advocates for individual level interventions that align with the root cause of the problem. An adapted interview guide was used to conduct in depth interviews, consisting of open-ended questions (Table S1). Each interview took approximately 60 to 90 min. The interviews were conducted in English, isiZulu, or Setswana depending on participants preference.
A digital translator was used to translate the data and verified by the transcriber. Private rooms were requested at the NPO to collect data, to ensure privacy and confidentiality for all potential participants including those that were identified at their “hotspot,” at Sivewright Street. Field notes were taken during the interviews and consolidated after each session to capture important details and researcher reflections. During data collection, participants were assured that their participation is voluntary, and they have the right to withdraw from the study at any given stage without any penalization. Interviews were conducted using the participants’ preferred language.
2.4. Sample Size and Sampling Technique
Purposive sampling technique was used to select participants who attend sessions at the NPO. The NPO provides services for PHHIVN from different age groups, ethnicity and genders with diverse backgrounds regardless of the duration of drug use and their HIV status. Attempts were made to achieve variety in the sample in terms of different genders, age, marital status, unemployment status, education level, years living with HIV and diagnose period. Purposive sampling technique was employed to select potential participants that represent similar characteristics. This sampling technique was best suited for this study, to identify a population category that has similar characteristics and to obtain detailed information and knowledge on the hurdles of accessing HIV treatment among PHHIVN in Mogale City, Gauteng Province.
2.5. Data Analysis
Qualitative data from audio recordings was used to generate transcripts. All 25 audio tapes recordings were first back translated from native languages to English, then transcribed into verbatim. The transcripts were imported to Nvivo 12 software for analysis. The authors independently read the transcripts thoroughly and repeatedly, to familiarize themselves with the data. Inductive thematic analysis approach was used to analyze data. Themes were generated from the data itself. The authors coded transcripts line by line to generate initial codes, which were then clustered into subcategories and broader themes. The supervisors and the independent co-coder analyzed the coded transcripts. The themes were presented in a meeting and where there were any discrepancies, they were discussed, and a consensus was reached. Coding discrepancies were discussed until consensus was achieved. No data was lost, all audio files, transcripts and notes were stored in password protected, encrypted folders accessible to the authors. Descriptive statistics were used to summarize participants’ demographic characteristics.
2.6. Trustworthiness
The researcher conducted the interviews. Before the participants left after the interviews, the information provided was confirmed with the notes to verify that the data obtained is a true reflection of participants’ intent. Themes were continuously refined through interactive comparison with the raw data to ensure they accurately reflected participants’ narratives. Credibility was ensured through recording of prolonged engagements with participants when conducting in-depth interviews. A thick description of the methodology and procedures was employed in this study, to allow application of the same methodology in a different settings and populations to ensure transferability. The supervisors kept an audit rail throughout the research process to ensure coherence of themes and used Nvivo software 14 for analysis.
3. Results
3.1. Socio-Demographics Characteristics of Participants
Sociodemographic Characteristics of PHHIVN
This study comprised of 25 participants. Their ages ranged from 20 to 49 years, with a mean age of 32.28 SD = ±5.54 years. Amongst the participants 21(84%) were males, 3(12%) were females and 1(4%) fell under the gender category of other. All 25 participants in the study were single. Most participants were unemployed at the time of the study, 24(96%), while a small proportion 1(4%) were employed. Nearly half of the participants 12(48%) had completed secondary education, a quarter had 6(24%) completed their matric, 3(12%) had tertiary education, 2(8%) had primary school education, and followed by another 2(8%) that had no formal education. With respect to HIV related data, 22(88%) of the participants were diagnosed with HIV after the use of nyaope, and 3(12%) were diagnosed with HIV before using nyaope (see Table 1 below).
3.2. Themes and Subthemes
Hurdles of Accessing HIV Treatment Among PHHIVN
This theme is about hurdles encountered by PHHIVN accessing HIV treatment. The participants revealed that social exclusion and fractured support system, nyaope dependence, withdrawal symptoms, peer pressure, socio-economic factors, misconception about the interaction between nyaope and HIV treatment were some of the hurdles faced by PHHIVN (refer to Table 2 below).
4. Discussion
The burden of HIV among PHHIVN remains a significant public health concern in many communities across South Africa. This study explored the hurdles of accessing HIV treatment among PHHIVN in Mogale City, Gauteng Province. The findings revealed six sub-themes as key barriers influencing access to HIV treatment: social exclusion and fractured support system, nyaope dependence, withdrawal symptoms, peer pressure, socio-economic factors, and misconception of the interaction between nyaope and HIV treatment.
Participants who took part in this study reported that PHHIVN are often subjected to stigma, moral judgement and abandonment by their families and communities, which affects their access to care. Similar studies also revealed perceived social exclusion as a major contributing factor to treatment discontinuation and a precursor to homelessness among PHHIVN [14,45,46]. In contrast, a study by [47], established that family support is positively correlated with enhanced adherence to HIV treatment and improved outcomes. Another study points out that substance use can cause moral stigma, resulting in exclusion from communal support structures [9]. Furthermore, individuals who use nyaope are often held in contempt within their communities, which not only amplifies shame but can also exacerbate further drug use as a coping mechanism [26]. Such experiences serve as a discouragement to seeking healthcare, particularly in public healthcare settings where families and community members are present.
Majority of the participants who took part in this study indicated that they spend most of their time and energy on finding money to buy nyaope rather than attending to their HIV treatment. This constant pursuit of funds is reflected in their dependency and their financial needs. Many participants reported that failure to obtain money for nyaope, result in avoidance to attend to their HIV treatment needs due to fear of withdrawal symptoms. As a result, their financial hardships serve as a dual barrier to their continued drug use while undermining adherence to their treatment. A similar study has identified financial constraints as a significant barrier to accessing HIV treatment [48]. Continuous engagement to HIV care is difficult when basic survival needs such as food, water, and shelter are unmet, underscoring the importance of integrating economic and social support within HIV programmes for PHHIVN.
Dependence on nyaope was found to be strongly linked to PHHIVN inability to maintain adherence to their HIV treatment. The participants disclosed that they have an uncontrollable craving for nyaope, which is essential for their daily functioning and emotional stability. Over prolonged use of nyaope, users develop dependency syndrome on the substance making it extremely difficult to cope without smoking nyaope on daily basis. This finding is supported by previous research that identified nyaope’s high addictive potential, which causes psychological and physiological dependence that is prioritized than their health needs [14]. Furthermore, ref. [14] it was also indicated that that the intense feelings experienced by PHHIVN when are out of nyaope causes feelings of helplessness and anxiety. The use of nyaope is addictive, hence PHHIVN find it difficult to cease smoking nyaope, an increase in smoking rate of nyaope leads to more desire.
The participants revealed withdrawal symptoms as a major barrier to accessing HIV treatment. These symptoms were commonly referred to as “cravings”, “alostros” or “down”, which include stomach cramps, sweating, loss of appetite, shivering, vomiting, dizziness, agitation, limited mobility, cold chills, diarrhoea and general body weakness. Such symptoms often intensified when participants attempted to reduce or delay nyaope use, which affect their endurance to long waiting times at the clinic. Similar findings were highlighted by previous research, that the physiological and psychological distress related to withdrawal symptoms can affect their treatment seeking behavior [16]. The severity and unpredictable nature of withdrawal symptoms act as a major deterrent to HIV treatment.
Peer influence emerged as a significant factor in shaping treatment behavior among PHHIVN said participants. Participants reported the difficulty of adhering to HIV treatment regimens in the presence of their peers. It was further reported by participants that instead of seeking their HIV treatment, they prefer to congregate with friends and smoke nyaope. According to a study by [16], peer influence frequently disrupts HIV treatment among homeless individuals who use nyaope. The study found that individuals using nyaope choose to smoke with peers rather than attend to their HIV treatment needs. Similarly, a study by [49], revealed that social groups that are characterized by similar practices of nyaope influences frequent use and relapse. Conversely, another study indicated that peer influence can often enhance cessation efforts and foster positive behaviour change [50]. Many PHHIVN prefer group settings to fulfil a sense of belonging, as they often face rejection by their families and communities. Influence from peers plays a huge role when it comes to adherence to HIV protocols. Therefore, support from peers can help improve HIV treatment adherence and harm reduction among PHHIVN by providing encouragement, motivation, and a safe space for them to continue with HIV treatment without fear of discrimination, stigma, or judgement.
Socio-economic factors such as unemployment, poverty, homelessness, know level of education, lack of shelter and food, and financial instability were revealed as some of the barriers to access HIV treatment among PHHIVN. Some of the participants indicated that their socioeconomic factors often force them to prioritize survival than to their HIV treatment. This aligns with prior studies indicating that people from low-income households often struggle to meet their basic needs, potentially prioritizing immediate survival over their healthcare requirements, including HIV treatment [51]. Homelessness further exacerbates these challenges by increasing the severity of HIV burden and diminishes access to treatment options [52]. Moreover, unemployment is associated with increased vulnerability and poor health outcomes due to limited access to stable income [53]. These socioeconomic conditions create an environment of instability and hinder adequate attendance to their HIV treatment.
PHHIVN, who took part in the study hold misconceptions that nyaope contains antiretroviral (ARV) components. The participants perceived that when consuming nyaope alongside prescribed HIV treatment could lead to harmful interactions. Contributing to treatment discontinuation, missed clinic appointment and reduced access to HIV services. Consequently, several participants deliberately discontinued their HIV treatment due to these perceived incompatibilities. This finding is consistent with the previous study indicating that misinformation and misconceptions surrounding drug interactions can significantly hinder adherence among people living with HIV [13]. Therefore, the misconception that smoking nyaope is equivalent to taking treatment, is attributed to lack of knowledge on HIV treatment composition and mechanism.
5. Conclusions
This study explored the hurdles of HIV treatment among PHHIVN in Mogale City, Gauteng Province, revealing multiple interrelated barriers to HIV treatment access including social exclusion and fractured support system, nyaope dependence, withdrawal symptoms, peer pressure, socio-economic factors, and misconception on the interaction between nyaope and HIV treatment The findings of this study highlight a critical gap in HIV and substance use education. The study identified a common misconception among PHHIVN holding a belief that smoking nyaope is equivalent to taking HIV treatment. Addressing this barrier requires targeted interventions integrated into harm reduction programmes and health care facilities. NPOs and community led programmes play an important role in peer education and substance use interventions. Strengthening collaboration between these services could further enhance HIV literary, eliminate misconceptions and improve HIV treatment. Furthermore, strengthening collaboration between healthcare providers, social workers, psychologists and nonprofit organizations is essential to improve adherence and retention to care among these individuals. For future research, longitudinal and mixed method studies are needed to examine the interventions that affect HIV treatment adherence and outcomes among nyaope users. Further chemical analyses could be beneficial in other provinces to help verify the persistence of ARV composition in nyaope.
6. Study Limitations and Strengths
The study was dominated by male gender and they young age group as participants. PHHIVN One strength of this study was choosing the NPO as the research setting. It provided easy access to participants who were directly involved in the topic, making it possible to gather rich and relevant data. However, the study was limited by the participants’ age and gender, as most respondents were males and fell within the age range of 20 to 39 years. This may affect how well the findings apply to other population groups across different geographical locations.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Barr D. Garnett G.P. Mayer K.H. Morrison M. Key populations are the future of the African HIV/AIDS pandemic J. Int. AIDS Soc.202124(Suppl. S 3)e 2575010.1002/jia 2.2575034189865 PMC 8242978 · doi ↗ · pubmed ↗
- 2Kessel B. Heinsohn T. Ott J.J. Wolff J. Hassenstein M.J. Lange B. Impact of COVID-19 pandemic and anti-pandemic measures on tuberculosis, viral hepatitis, HIV/AIDS and malaria–a systematic review PLOS Glob. Public Health 20233 e 000101810.1371/journal.pgph.000101837126484 PMC 10150989 · doi ↗ · pubmed ↗
- 3Chamie G. Napierala S. Agot K. Thirumurthy H. HIV testing approaches to reach the first UNAIDS 95% target in sub-Saharan Africa Lancet HIV 20218 e 225e 23610.1016/S 2352-3018(21)00023-033794183 · doi ↗ · pubmed ↗
- 4Pham M.D. Nguyen H.V. Anderson D. Crowe S. Luchters S. Viral load monitoring for people living with HIV in the era of test and treat: Progress made and challenges ahead–a systematic review BMC Public Health 202222120310.1186/s 12889-022-13504-235710413 PMC 9202111 · doi ↗ · pubmed ↗
- 5Uwishema O. Taylor C. Lawal L. Hamiidah N. Robert I. Nasir A. Chalhoub E. Sun J. Akin B.T. Adanur I. The syndemic burden of HIV/AIDS in Africa amidst the COVID-19 pandemic Immun. Inflamm. Dis.202210263210.1002/iid 3.54434606689 PMC 8652687 · doi ↗ · pubmed ↗
- 6Kumah E. Boakye D.S. Boateng R. Agyei E. Advancing the global fight against HIV/Aids: Strategies, barriers, and the road to eradication Ann. Glob. Health 2023898310.5334/aogh.427738046536 PMC 10691281 · doi ↗ · pubmed ↗
- 7Ezezew M. Yehualaw A. Demsie D.G. Assessment of availability and challenges of WHO recommended priority life-saving medicines for under five-year children in primary public health facilities of Amhara region BMC Pediatr.20232339510.1186/s 12887-023-04216-637558993 PMC 10413804 · doi ↗ · pubmed ↗
- 8Charlton R.W. Negota A. Mistry D. An exploration into nyaope users and interventions to curb drug abuse in Gauteng, South Africa Int. J. Humanit. Soc. Sci. Invent.201911425
